RARS2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.269400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.888000E-02
Normal-vs-Stage2
2.932600E-01
Normal-vs-Stage3
3.418000E-01
Normal-vs-Stage4
2.232600E-01
Stage1-vs-Stage2
3.110200E-01
Stage1-vs-Stage3
6.681800E-01
Stage1-vs-Stage4
8.962600E-03
Stage2-vs-Stage3
7.715200E-01
Stage2-vs-Stage4
2.041500E-02
Stage3-vs-Stage4
7.439900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.135400E-01
Normal-vs-AfricanAmerican
6.957200E-01
Normal-vs-Asian
2.890400E-01
Caucasian-vs-AfricanAmerican
4.921000E-01
Caucasian-vs-Asian
3.327200E-01
AfricanAmerican-vs-Asian
3.718200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.905400E-01
Normal-vs-Female
3.958600E-01
Male-vs-Female
4.275600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.021700E-02
Normal-vs-Age(41-60Yrs)
5.330200E-01
Normal-vs-Age(61-80Yrs)
2.842800E-01
Normal-vs-Age(81-100Yrs)
2.173000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.435700E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.453400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.077990E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.579700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.374800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.002200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.027600E-01
Normal-vs-Daily Drinker
1.791540E-02
Normal-vs-Weekly Drinker
6.553800E-01
Normal-vs-Occasional Drinker
5.600800E-01
Normal-vs-Social Drinker
5.394400E-01
Non Drinker-vs-Daily Drinker
1.467000E-01
Non Drinker-vs-Weekly Drinker
2.412400E-01
Non Drinker-vs-Occasional Drinker
1.542960E-01
Non Drinker-vs-Social Drinker
1.915240E-01
Daily Drinker-vs-Weekly Drinker
4.748100E-02
Daily Drinker-vs-Occasional Drinker
5.016900E-03
Daily Drinker-vs-Social Drinker
7.401700E-03
Weekly Drinker-vs-Occasional Drinker
9.894600E-01
Weekly Drinker-vs-Social Drinker
9.822600E-01
Occasional Drinker-vs-Social Drinker
9.654400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.552000E-01
Normal-vs-Grade 2
8.862000E-01
Normal-vs-Grade 3
8.782200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.565200E-01
Grade 1-vs-Grade 3
6.136000E-01
Grade 1-vs-Grade 4
8.552000E-01
Grade 2-vs-Grade 3
8.168600E-01
Grade 2-vs-Grade 4
8.862000E-01
Grade 3-vs-Grade 4
8.782200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.109000E-01
Normal-vs-NonDiabetic
2.562200E-01
Diabetic-vs-NonDiabetic
7.508200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.535500E-02
Normal-vs-NoPancreatitis
2.933200E-01
Pancreatitis-vs-NoPancreatitis
2.223000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.378800E-01
Normal-vs-N1
3.015800E-01
N0-vs-N1
5.422000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.454000E-01
Normal-vs-TP53-NonMutant
4.879000E-01
TP53-Mutant-vs-TP53-NonMutant
9.083400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
